Nonoperating Income (Expense) of TuHURA Biosciences, Inc./NV from 31 Dec 2011 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TuHURA Biosciences, Inc./NV quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2011 to 30 Sep 2024.
  • TuHURA Biosciences, Inc./NV Nonoperating Income (Expense) for the quarter ending 30 Sep 2024 was $48,000.
  • TuHURA Biosciences, Inc./NV Nonoperating Income (Expense) for the twelve months ending 30 Sep 2024 was $179,000, a 85% increase year-over-year.
  • TuHURA Biosciences, Inc./NV annual Nonoperating Income (Expense) for 2024 was $131,000, a 11% decline from 2023.
  • TuHURA Biosciences, Inc./NV annual Nonoperating Income (Expense) for 2023 was $147,000, a 600% increase from 2022.
  • TuHURA Biosciences, Inc./NV annual Nonoperating Income (Expense) for 2022 was $21,000.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

TuHURA Biosciences, Inc./NV Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $179,000 $48,000 +$48,000 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $131,000 $61,000 +$47,000 +336% 01 Apr 2024 30 Jun 2024 10-K 07 Oct 2024 2024 FY
Q1 2024 $84,000 $74,000 +$36,000 +95% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q3
Q4 2023 $48,000 $4,000 -$49,000 -109% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $97,000 $0 -$50,000 -100% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q2 2023 $147,000 $14,000 +$2,000 +17% 01 Apr 2023 30 Jun 2023 10-K 07 Oct 2024 2024 FY
Q1 2023 $145,000 $38,000 +$36,000 +1800% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q3
Q4 2022 $109,000 $45,000 +$43,000 +2150% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 $66,000 $50,000 +$45,000 +900% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2024 Q1
Q2 2022 $21,000 $12,000 +$46,000 01 Apr 2022 30 Jun 2022 10-K 18 Sep 2023 2023 FY
Q1 2022 $25,000 $2,000 +$32,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q3
Q4 2021 $57,000 $2,000 +$37,000 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q2
Q3 2021 $94,000 $5,000 +$38,000 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q2 2021 $132,000 $34,000 -$32,000 -1600% 01 Apr 2021 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q1 2021 $100,000 $30,000 -$49,000 -258% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q3
Q4 2020 $51,000 $35,000 -$61,000 -235% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022 2022 Q2
Q3 2020 $10,000 $33,000 -$62,000 -214% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q1
Q2 2020 $72,000 $2,000 -$318,664 -101% 01 Apr 2020 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 $390,664 $19,000 +$11,611 +157% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q3
Q4 2019 $379,053 $26,000 +$13,564 +109% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2021 2021 Q2
Q3 2019 $365,489 $29,000 +$15,214 +110% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q2 2019 $350,275 $316,664 +$359,689 01 Apr 2019 30 Jun 2019 10-K 18 Sep 2020 2020 FY
Q1 2019 $9,414 $7,389 +$5,799 +365% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q3
Q4 2018 $15,213 $12,436 +$20,210 01 Oct 2018 31 Dec 2018 10-Q 13 Feb 2020 2020 Q2
Q3 2018 $35,423 $13,786 +$928 +7.2% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q2 2018 $36,351 $43,025 -$237,066 -122% 01 Apr 2018 30 Jun 2018 10-K 09 Sep 2019 2019 FY
Q1 2018 $200,715 $1,590 +$85,818 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q3
Q4 2017 $114,897 $7,774 -$377,997 -102% 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q2
Q3 2017 $492,894 $12,858 +$253,829 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q2 2017 $239,065 $194,041 -$1,753,344 -90% 01 Apr 2017 30 Jun 2017 8-K 03 Jun 2019
Q1 2017 $1,992,409 $84,228 -$364,376 -130% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q3
Q4 2016 $2,356,785 $370,223 -$596,608 -62% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018 2018 Q2
Q3 2016 $2,953,393 $240,971 +$302,547 +56% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $2,650,846 $1,947,385 +$1,675,246 +616% 01 Apr 2016 30 Jun 2016 10-K 27 Sep 2017 2017 FY
Q1 2016 $975,600 $280,148 +$1,224,275 01 Jan 2016 31 Mar 2016 10-Q 12 May 2016 2016 Q3
Q4 2015 $248,675 $966,831 +$318,066 +49% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017 2017 Q2
Q3 2015 $566,741 $543,518 -$943,627 -236% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q2 2015 $376,886 $272,139 +$5,064,887 01 Apr 2015 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q1 2015 $4,688,001 $944,127 -$2,556,942 -159% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q3
Q4 2014 $2,131,059 $648,765 +$985,031 01 Oct 2014 31 Dec 2014 10-Q 12 Feb 2016 2016 Q2
Q3 2014 $3,116,090 $400,109 +$8,495,944 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2016 Q1
Q2 2014 $11,612,034 $4,792,748 -$217,914 -4.8% 01 Apr 2014 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q1 2014 $11,394,120 $1,612,815 +$7,465,810 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q4 2013 $18,859,930 $336,266 -$619,746 -219% 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015 2015 Q2
Q3 2013 $18,240,184 $8,095,835 -$8,116,230 -39795% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1
Q2 2013 $10,123,954 $4,574,834 -$4,565,060 -46706% 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 $5,558,894 $5,852,995 -$5,863,625 -55161% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q4 2012 $304,731 $283,480 01 Oct 2012 31 Dec 2012 10-K 28 Aug 2014 2014 FY
Q3 2012 $20,395 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3
Q2 2012 $9,774 01 Apr 2012 30 Jun 2012 10-Q 12 Aug 2013 2013 Q2
Q1 2012 $10,630 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1

TuHURA Biosciences, Inc./NV Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $131,000 -$16,000 -11% 01 Jul 2023 30 Jun 2024 10-K 07 Oct 2024 2024 FY
2023 $147,000 +$126,000 +600% 01 Jul 2022 30 Jun 2023 10-K 07 Oct 2024 2024 FY
2022 $21,000 +$153,000 01 Jul 2021 30 Jun 2022 10-K 18 Sep 2023 2023 FY
2021 $132,000 -$204,000 -283% 01 Jul 2020 30 Jun 2021 10-K 27 Sep 2022 2022 FY
2020 $72,000 -$278,275 -79% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021 2021 FY
2019 $350,275 +$386,626 01 Jul 2018 30 Jun 2019 10-K 18 Sep 2020 2020 FY
2018 $36,351 -$275,416 -115% 01 Jul 2017 30 Jun 2018 10-K 09 Sep 2019 2019 FY
2017 $239,065 -$2,411,781 -91% 01 Jul 2016 30 Jun 2017 8-K 03 Jun 2019
2016 $2,650,846 +$2,273,960 +603% 01 Jul 2015 30 Jun 2016 10-K 27 Sep 2017 2017 FY
2015 $376,886 +$11,988,920 01 Jul 2014 30 Jun 2015 10-K 13 Sep 2016 2016 FY
2014 $11,612,034 -$9,616,306 -482% 01 Jul 2013 30 Jun 2014 10-K 16 Nov 2015 2015 FY
2013 $1,995,728 -$2,300,459 -755% 01 Jan 2013 31 Dec 2013 10-K 28 Aug 2014 2014 FY
2012 $304,731 +$344,801 01 Jan 2012 31 Dec 2012 10-K 28 Aug 2014 2014 FY
2011 $40,070 01 Jan 2011 31 Dec 2011 10-K 10 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.